REGN

Regeneron Pharmaceuticals, Inc. News Headlines

$384.46
*  
3.45
0.91%
Get REGN Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading REGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog
10/22/2014 11:18:00 AM - Zacks.com


InsiderInsights.com Daily Round Up 10/20/14: REGN, OPK, AGCO, HSON
10/21/2014 9:35:00 AM - Seeking Alpha


Sanofi and Regeneron Dose Patients in Dupilumab Study - Analyst Blog
10/20/2014 5:45:00 PM - Zacks.com


Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog
10/20/2014 5:10:00 PM - Zacks.com


Best U.S. Stock Ideas Today: 10/20/14
10/20/2014 4:59:00 PM - Seeking Alpha


Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape
10/20/2014 9:39:00 AM - Zacks.com


Regeneron, Sanofi Begins Phase 3 Trial Of Dupilumab - Quick Facts
10/20/2014 7:15:00 AM - RTT News


Sanofi, Regeneron Begin Phase 3 Study For Eczema Drug Dupilumab
10/20/2014 2:16:00 AM - RTT News


Cramer's Lightning Round - Ensco Is One Of The Worst Stocks I've Owned In My Life (10/17/14)
10/19/2014 6:24:00 AM - Seeking Alpha


InsiderInsights.com Daily Round Up 10/17/14: REGN, KEY, ALSN, AGCO
10/18/2014 9:55:00 AM - Seeking Alpha


Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog
10/17/2014 6:15:00 PM - Zacks.com


4 Big Stocks on Traders' Radars
10/17/2014 3:14:00 PM - TheStreet


Friday's ETF Movers: BBH, GDX
10/17/2014 2:39:46 PM - BNK Invest


S&P 500 Analyst Moves: REGN
10/17/2014 2:38:20 PM - BNK Invest


Amgen Files Patent Infringement Suit Over Cholesterol Drug
10/17/2014 1:25:00 PM - Dow Jones Business News


Nasdaq 100 Movers: NFLX, XLNX
10/17/2014 12:37:49 PM - BNK Invest


Cramer: Regeneron's Head-to-Head Results 'Very Positive'
10/17/2014 11:46:00 AM - TheStreet


Regeneron Pharmaceuticals Inc. (REGN) Is Up Sharply On Study Results
10/17/2014 9:37:00 AM - RTT News


Amgen Files Patent Infringement Lawsuit Against Sanofi And Regeneron
10/17/2014 9:08:00 AM - RTT News


Regeneron Pharma's EYLEA Injection Shows Greater Gains In Visual Acuity
10/17/2014 7:15:00 AM - RTT News


Cramer's Lightning Round - You Get Good News From Regeneron (10/16/14)
10/17/2014 6:08:00 AM - Seeking Alpha


Ohr Pharmaceutical's OHR-102 to Enter Phase III in 1H15 - Analyst Blog
10/16/2014 7:00:00 PM - Zacks.com


Bristol-Myers Collaborates for Opdivo-Imbruvica Combo - Analyst Blog
10/14/2014 5:20:00 PM - Zacks.com


Celgene's Otezla Encourages in Plaque Psoriasis at EADV - Analyst Blog
10/13/2014 5:19:00 PM - Zacks.com


Ohr Pharamceuticals: Stay On The Sidelines
10/10/2014 7:45:00 AM - Seeking Alpha